(Q43621485)

25 November 2017

Studies on oestrogen receptor-alpha and -beta mRNA in breast cancer (English)

1 reference

25 November 2017

1 reference

Cullen R

1

1 reference

25 November 2017

Maguire TM

2

1 reference

25 November 2017

McDermott EW

3

1 reference

25 November 2017

Hill AD

4

1 reference

25 November 2017

O'Higgins NJ

5

1 reference

25 November 2017

Duffy MJ

6

1 reference

25 November 2017

1 June 2001

1 reference

European Journal of Cancer

25 November 2017

1 reference

25 November 2017

37

1 reference

25 November 2017

9

1 reference

25 November 2017

1118-1122

1 reference

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900088-0

7 January 2021

Cloning of a novel receptor expressed in rat prostate and ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900088-0

7 January 2021

The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900088-0

7 January 2021

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900088-0

7 January 2021

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900088-0

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900088-0

7 January 2021

Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900088-0

7 January 2021

10.1016/S0959-8049(01)00088-0

Identifiers

DOI

1 reference

25 November 2017

1 reference